Compare NNNN & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | YRD |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.2M | 321.4M |
| IPO Year | 2023 | 2015 |
| Metric | NNNN | YRD |
|---|---|---|
| Price | $6.81 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.5K | 52.1K |
| Earning Date | 04-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | ★ 23.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $446.57 | ★ $1.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.08 | $0.82 |
| 52 Week High | $51.33 | $6.79 |
| Indicator | NNNN | YRD |
|---|---|---|
| Relative Strength Index (RSI) | 26.92 | 43.65 |
| Support Level | N/A | $1.04 |
| Resistance Level | $12.62 | $1.29 |
| Average True Range (ATR) | 1.62 | 0.07 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 3.06 | 28.43 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.